Recombinant Human Carbonic Anhydrase 1 Protein，His

Carbonic Anhydrase 1 (CA1) is an enzyme that has garnered significant attention in biochemical and medical research due to its pivotal role in the regulation of pH and CO2 concentration in biological systems. This enzyme catalyzes the reversible hydration of carbon dioxide to bicarbonate and protons, which is crucial for various physiological processes, including respiration, acid-base balance, and photosynthesis in plants. Its dysfunction has been linked to numerous pathological conditions, including glaucoma, epilepsy, and certain types of cancer, making it a potential target for therapeutic intervention. The recombinant expression of CA1 provides a valuable tool for studying its structure-function relationships and developing inhibitors that could serve as drugs. Advances in molecular cloning and protein expression systems have enabled researchers to produce large quantities of highly purified CA1 for kinetic studies, structural analysis, and drug screening. Understanding the enzymatic mechanisms and regulation of CA1 at the molecular level can contribute to the development of novel pharmacological agents and enhance our comprehension of its biological significance in health and disease. Additionally, the study of CA1 is not only vital for its implications in human health but also offers insights into the evolutionary aspects of carbonic anhydrases across different organisms, illuminating their diverse functions and adaptations. Overall, research on recombinant CA1 is essential for both basic science and the potential development of clinical applications aimed at modulating its activity for therapeutic benefits.